3 HATNUFA ST., YOKNEAM ILIT, L3
Lifeward Ltd. Enters Amended and Restated Senior Secured Convertible Note
Other Events
Reports First Quarter 2026 Financial Results
Jeannine Lynch Departs as VP of Strategy at Lifeward Ltd.
Lifeward Ltd Completes Acquisition of Oratech Pharma
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Reports Fourth Quarter and Full Year 2025 Financial Results Advancing Transformation into a Diversified Biomedical Innovation Company with a Clear Path to Cash Flow Positive
Q1
Notice of Late Filing for Quarterly Report
FY 2025
Q3
Q2
FY 2024
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Merger Proxy Statement
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Specialized Disclosure Report
Delisting Amendment
PREM14A
Correspondence
S-8 POS